Inorganic Scintillators Market by Scintillation Material: Future Growth & Opportunities

By -

Inorganic Scintillators Market categorizes the Global Market by Application (Healthcare, Nuclear Power Plants, Homeland Security & Defense), Type (Alkali Halides, Rare Earth Metals), Scintillation Material (LSO & LYSO, NaI, CsI, ) & Geography

(EMAILWIRE.COM, August 07, 2018 ) The inorganic scintillators market is expected to reach USD 330.7 Million in 2021 from USD 256.1 Million in 2016, growing at a CAGR of 5.2%. Growing safety concerns post the Fukushima disaster, growing security threats, growing security budgets of global sporting events, increasing incidence of cancer, growth in the number of PET/CT scans, and growing threat of nuclear terrorism are expected to drive the growth of the market in the coming years.

The global inorganic scintillators market is segmented on the basis of scintillation material, type, and application. By scintillation material, the market is categorized into sodium iodide (NaI), cesium iodide (CsI), bismuth germanate (BGO), lutetium oxyorthosilicate (LSO) and lutetium –yttrium oxyorthosilicate (LYSO), and other scintillation materials [barium fluoride (BaF2), lead tungstate (PbWO4), cadmium tungstate (CdWO4), cerium bromide (CeBr3), lanthanum bromide (LaBr3), and gadolinium orthosilicate (GSO)]. The sodium iodide (NaI) is estimated to account for the largest share of the global market. Rising application horizon of sodium iodide, increasing homeland security expenditure to combat terrorism worldwide, and rising number of nuclear power plants are some of the reasons contributing to the growth of the market. The lutetium oxyorthosilicate (LSO) & lutetium-yttrium oxyorthosilicate (LYSO) segment is expected to grow at the highest rate during the forecast period (2016-2021).

Know More: https://www.marketsandmarkets.com/Market-Reports/inorganic-scintillators-market-121799348.html

This is mainly due to its benefits over other scintillators, increasing research activities in the field of high-energy and nuclear physics, and rising demand for PET scanners worldwide. Due to distinguished properties of LSO and LYSO, especially their higher light output and short decay time as compared to BGO, they can potentially replace BGO in many applications.

On the basis of region, this market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. The U.S. is the largest market in North America, owing to the increasing prevalence of cancer, rising adoption of nuclear imaging systems, government initiatives, increase in the number of nuclear power plants in the U.S., growing security concerns, and rising number of conferences. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=121799348

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more